Product Code: GVR-3-68038-952-4
U.S. Donor Egg IVF Services Market Growth & Trends:
The U.S. donor egg IVF services market size is anticipated to reach USD 520.5 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 4.4% from 2025 to 2030. Increasing demand for eggs in the U.S. can be attributed to delayed childbearing, improved success rate of IVF procedures, and growing acceptance of fertility treatments.
Additionally, laws for egg donation are not stringent in many states in the country. Hence, residents from European and Asian countries where egg donations and surrogacy procedures are illegal, visit the U.S. for infertility treatment services. Rising medical tourism when it comes to IVF is also expected to boost the U.S. market in the coming years.
Major players offering these services in the regional market include Beverly Hills Egg Donation, Donor Egg Bank USA, Egg Donor America, MyEggBank, Extraordinary Conceptions LLC, Premier Egg Donors, California Fertility Partner, Extend Fertility, Boston IVF, and Fairfax EggBank. Mergers, acquisitions, and collaborations are some of the key strategies adopted by players to strengthen their presence in the market. For instance, in February 2017, Instituto Valenciano de Infertilidad (IVI) announced its foray in the U.S. by entering into an agreement to merge with Reproductive Medicine Associates of New Jersey, LLC (RMANJ). This agreement was aimed at making IVI-RMA Global the world's largest group of assisted reproduction.
U.S. Donor Egg IVF Services Market Report Highlights:
- The fresh donor eggs segment dominated the U.S. donor egg IVF services industry with a revenue share of 71.2% in 2024 and is projected to witness the highest CAGR of 9.7% over the forecast period.
- The frozen donor eggs segment is expected to grow significantly over the forecast period, driven by advancements in vitrification technology, which have enhanced the survival rates of frozen eggs, making them a reliable fertility preservation option.
- The fertility clinics segment dominated the U.S. donor egg IVF services industry with the largest revenue share in 2024 and is projected to witness the highest CAGR over the forecast period
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. End Use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Donor Egg IVF Services Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
Chapter 4. U.S. Donor Egg IVF Services Market: Type Business Analysis
- 4.1. Type Market Share, 2024 & 2030
- 4.2. Type Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 4.4. Fresh Donor Eggs
- 4.4.1. Fresh Donor Eggs Market, 2018 - 2030 (USD Million)
- 4.5. Frozen Donor Eggs
- 4.5.1. Frozen Donor Eggs Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Donor Egg IVF Services Market: End Use Business Analysis
- 5.1. End Use Market Share, 2024 & 2030
- 5.2. End Use Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 5.4. Fertility Clinics
- 5.4.1. Fertility Clinics Market, 2018 - 2030 (USD Million)
- 5.5. Hospitals and Other Settings
- 5.5.1. Hospitals and Other Settings Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
- 6.1. Participant Overview
- 6.2. Company Market Position Analysis
- 6.3. Company Categorization
- 6.4. Strategy Mapping
- 6.5. Company Profiles/Listing
- 6.5.1. Shady Grove Fertility
- 6.5.1.1. Overview
- 6.5.1.2. Financial Performance
- 6.5.1.3. Type Benchmarking
- 6.5.1.4. Strategic Initiatives
- 6.5.2. Hamilton Thorne
- 6.5.2.1. Overview
- 6.5.2.2. Financial Performance
- 6.5.2.3. Type Benchmarking
- 6.5.2.4. Strategic Initiatives
- 6.5.3. Seattle Reproductive Medicine, Inc.
- 6.5.3.1. Overview
- 6.5.3.2. Financial Performance
- 6.5.3.3. Type Benchmarking
- 6.5.3.4. Strategic Initiatives
- 6.5.4. Fertility Centers of Illinois
- 6.5.4.1. Overview
- 6.5.4.2. Financial Performance
- 6.5.4.3. Type Benchmarking
- 6.5.4.4. Strategic Initiatives
- 6.5.5. New Hope Fertility Clinic
- 6.5.5.1. Overview
- 6.5.5.2. Financial Performance
- 6.5.5.3. Type Benchmarking
- 6.5.5.4. Strategic Initiatives
- 6.5.6. Weill Cornell Medicine.
- 6.5.6.1. Overview
- 6.5.6.2. Financial Performance
- 6.5.6.3. Type Benchmarking
- 6.5.6.4. Strategic Initiatives
- 6.5.7. CCRM Fertility
- 6.5.7.1. Overview
- 6.5.7.2. Financial Performance
- 6.5.7.3. Type Benchmarking
- 6.5.7.4. Strategic Initiatives
- 6.5.8. RMA Network
- 6.5.8.1. Overview
- 6.5.8.2. Financial Performance
- 6.5.8.3. Type Benchmarking
- 6.5.8.4. Strategic Initiatives
- 6.5.9. RADfertility
- 6.5.9.1. Overview
- 6.5.9.2. Financial Performance
- 6.5.9.3. Type Benchmarking
- 6.5.9.4. Strategic Initiatives
- 6.5.10. Pinnacle
- 6.5.10.1. Overview
- 6.5.10.2. Financial Performance
- 6.5.10.3. Type Benchmarking
- 6.5.10.4. Strategic Initiatives